Cardiovascular Complications of Coronavirus Disease-2019

Carmen M Terzic; Betsy J Medina-Inojosa

doi:10.1016/j.pmr.2023.03.003

Cardiovascular Complications of Coronavirus Disease-2019

Phys Med Rehabil Clin N Am. 2023 Aug;34(3):551-561. doi: 10.1016/j.pmr.2023.03.003. Epub 2023 Mar 31.

Authors

Carmen M Terzic¹, Betsy J Medina-Inojosa²

Affiliations

¹ Department of Physical Medicine and Rehabilitation, Cardiovascular Rehabilitation, Rehabilitation Medicine Research Center, Mayo Clinic, 200 First Street Southwest, Rochester, MN 55905, USA; Division of Preventive Cardiology, Department of Cardiovascular Medicine, Mayo Clinic, 200 First Street Southwest, Rochester, MN 55905, USA. Electronic address: Terzic.carmen@mayo.edu.
² Division of Preventive Cardiology, Department of Cardiovascular Medicine, Mayo Clinic, 200 First Street Southwest, Rochester, MN 55905, USA.

Abstract

Cardiovascular complications associated with the severe acute respiratory syndrome coronavirus 2 infection are common and lead to high mortality in the acute phase and high morbidity in the chronic phase impacting an individual's quality of life and health outcomes. Patients afflicted with coronavirus disease-2019 (COVID-19) infection display an increased risk for myocarditis, dysrhythmia, pericarditis, ischemic heart disease, heart failure, and thromboembolism. Although cardiovascular complications are reported across all patients with COVID-19, hospitalized patients with severe infection are most vulnerable. The underline pathobiology remains poorly defined albeit complex. Following current guidelines in decision-making for evaluation and management in addition to the beginning or returning exercise is recommended.

Keywords: COVID-19; Cardiac; Cardiovascular complications COVID-19; Dysrhythmia; Heart failure; Myocarditis; Post-acute sequelae of SARS-CoV-2 infection.

Publication types

Review

MeSH terms

COVID-19* / complications
Cardiovascular Diseases* / complications
Humans
Myocarditis* / etiology
Quality of Life
SARS-CoV-2